Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma.

about

Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients

P2860

Q28066710-FE2E7695-D08C-4CBF-B7B9-596C1239592F

P2860

Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma.

Item

http://www.wikidata.org/entity/Q40744550

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Favorable survival after allog ...... efractory follicular lymphoma.

@en

type

Item

label

Favorable survival after allog ...... efractory follicular lymphoma.

@en

prefLabel

Favorable survival after allog ...... efractory follicular lymphoma.

@en

P1476

Favorable survival after allog ...... refractory follicular lymphoma

@en

P2093

C Nakaseko

http://www.w3.org/2001/XMLSchema#string

H Kanamori

http://www.w3.org/2001/XMLSchema#string

J Kato

http://www.w3.org/2001/XMLSchema#string

K Shono

http://www.w3.org/2001/XMLSchema#string

Kanto Study Group for Cell Therapy (KSGCT)

http://www.w3.org/2001/XMLSchema#string

N Aotsuka

http://www.w3.org/2001/XMLSchema#string

N Tomita

http://www.w3.org/2001/XMLSchema#string

R Sakai

http://www.w3.org/2001/XMLSchema#string

S Fujisawa

http://www.w3.org/2001/XMLSchema#string

S Okamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial.

Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: the phase II VERTICAL study.

Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials.

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research

Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.

Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901

Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.

Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

P2888

bmt.2015.158

P304

1299-1305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2015.158

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nobuhiko Kobayashi

P577

2015-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280059823

http://www.w3.org/2001/XMLSchema#string

P6179

1032439247

http://www.w3.org/2001/XMLSchema#string

P698

26168068

http://www.w3.org/2001/XMLSchema#string

Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma.

about

P2860

P2860

Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698